Tg(MMTV-KRAS*G12V)3025Mrl
Transgene Detail
|
Symbol: |
Tg(MMTV-KRAS*G12V)3025Mrl |
Name: |
transgene insertion 3025, Merck Research Laboratory |
MGI ID: |
MGI:5827748 |
Synonyms: |
MMTV-Ki-rasB |
Transgene: |
Tg(MMTV-KRAS*G12V)3025Mrl Location: unknown
|
Alliance: |
Tg(MMTV-KRAS*G12V)3025Mrl page
|
|
Strain of Origin: |
C57BL/6 x SJL
|
|
Transgene Type: |
|
Transgenic (Constitutively active, Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(MMTV-KRAS*G12V)3025Mrl expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
KRAS (3845) |
|
the G12V mutation renders KRAS constitutively active |
|
|
|
Mutation details: This transgene consists of the mouse mammary tumor virus long terminal repeat (MMTV LTR), 5'-untranslated region from the HaSv, sequences encoding oncogenically mutated (glycine to valine at codon 12) human Kirsten (Ki)-rasB, and SV40 polyadenylation sequence. Highest level of transgene expression is in mammary tissue and no expression is seen in the kidney, liver or spleen.
(J:77272)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:77272 Omer CA, et al., Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor. Cancer Res. 2000 May 15;60(10):2680-8 |
All: |
2 reference(s) |
|